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CRISPR (clustered regularly interspaced short
palindromic repeats) loci function in tandem with the
adjacent operon of Cas (CRISPR associated) pro-
teins to provide prokaryotes with an RNA-based
adaptive immune system against foreign genetic
elements (reviewed in Ref. [1]). The centerpiece of
all CRISPR-Cas systems is a large ribonucleoprotein
interference complex that uses a single-stranded
crRNA (CRISPR RNA) for nucleic acid targeting and
allows for the subsequent degradation [2]. The
ribonucleoproteins come in different flavors for each
of the three major CRISPR types (types I–III) and
the multiple subtypes therein. They have been under
intense structural and mechanistic characterization.
CRISPR-Cas systems are stringently classified into
one of three types based on the presence of the
signature protein in their Cas operon [3] and less
formally classified by the general architecture of their
interference complexes. Type I systems utilize the
Cascade (CRISPR associated complex for antiviral
defense), a multi-subunit complex composed of five
different proteins and a crRNA. TheCascade employs
the associated crRNA to locate and invade matching
double-stranded DNA and for the target degradation
by the signature nuclease–helicase enzyme Cas3
[2,3]. Electronmicroscopyand crystal structures of the
Cascade in both apoform and single-stranded DNA
bound forms are now available [4–7]. In addition, the
crystal structure of Cas3 bound to a single-stranded
DNA substrate has been determined [8]. Therefore,
the frontier of the field has shifted toward understand-
ing mechanistic details regarding the Cascade-me-
diated recruitment of Cas3 and the subsequent
substrate degradation. Type II systems use the single
large signature protein Cas9 to carry out crRNA-
guided targeting and degradation of double-stranded
DNA; a trans-encoded RNA assists the process
[9,10]. The simplicity of this CRISPR type enabledhed by Elsevier Ltd.creative development of genome engineering appli-
cations [11]. Several crystal structures of the type II
system (Cas9) contribute to the rapid evolvement of
practical applications [12–14].
A similar story is currently unfolding for the type III
CRISPR system, although many structural and mech-
anistic details remain elusive. Type III CRISPR
systems can be further divided into the type III-A
DNA targeting Csm complex and the type III-B RNA
targeting Cmr complex [1]. The type III-A Csm complex
contains crRNA and the five proteins Csm1–Csm5,
where Csm1 is the signature protein Cas10 [3,15].
An electron microscopy reconstruction of the type III-A
Csm complex from Sulfolobus solfataricus illustrated
an overall helical architecture, with Csm1 and Csm4 at
the foot of the complex followed by the multi-copy
helical backbone of Csm3, which resembles the Cas7
backbone seen in type I systems [16]. In addition,
an independent crystal structure of Csm3 from
Methanopyrus kandleri (MkCsm3) also revealed struc-
tural similarity with the Cas7 family of proteins, further
supporting its role as the backbone protein of the Csm
complex [17]. The type III-B Cmr complex contains
crRNA and the proteins Cmr1–Cmr6, where Cmr2 is
the signature protein Cas10 [2]. There are currently
two electron microscopy reconstructions of the Cmr
complex from Pyrococcus furiosus [18] and Thermus
thermophilus [19], both of which display the conserved
helical architecture shared among type I and type III-A
systems. Furthermore, crystal structures have been
solved for Cmr1 [20], Cmr2 [20,21], Cmr4 [20] and
Cmr6 [20], as well as a Cmr2–Cmr3 subcomplex [22].
In contrast to the rapid accumulation of structural
information for type III-B systems, knowledge for
the type III-A system has been limited to the overall
arrangement of protein subunits, as illustrated by
electron microscopy, and a single crystal structure of
MkCsm3. High-resolution structural information and
mechanistic details remained largely unavailable for
the remaining Csm complex components to this point.J. Mol. Biol. (2015) 427, 228–230
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Subcomplex from Methanococcus
jannaschii Type III-A System
The work conducted here by Numata et al. pro-
ceeded first by the investigation of physical interactions
among subunits of the M. jannaschii Csm (MjCsm)
complex [23]. Using size-exclusion chromatography,
they demonstrated the existence of several stable
subcomplexes, in the absence of crRNA, including
MjCsm1–MjCsm4, MjCsm3–MjCsm4 and the ternary
complex MjCsm1–MjCsm4–MjCsm3.
Structure determination efforts followed. The au-
thors solved the crystal structure of the MjCsm3–
MjCsm4 complex at 3.1 Å and showed that it
contained three ferredoxin-like folds, one in MjCsm3
and two in MjCsm4. The MjCsm4 component was
found to contain significant structural similarity to
Cmr3 from P. furiosus [22] (3.13 Å r.m.s.d. for 190
aligned Cα atoms) regardless of quite low level of
sequence identity (15.3%). This was consistent with
the fact that both Csm4 and Cmr3 are orthologs of
Cas5 from the type I system, which is responsible for
the binding of the crRNA 5′ handle [6,7]. As expected,
the MjCsm3 component was structurally quite similar
to the previously determined MkCsm3 structure
(1.89 Å r.m.s.d. for 177 aligned Cα atoms). Align-
ments did reveal structural insertions in MkCsm3 that
are not found in MjCsm3; however, these elements
are outside the proposed Csm3–Csm4 interface and
therefore are not expected to interfere. Therefore, the
authors concluded that the mechanism of subunit
assembly is likely conserved in the type III-A subtype.
An analysis of the interface between MjCsm3 and
MjCsm4 illustrated two main interactions: (1) The α1
and α7 helices of MjCsm4 interact with an antipar-
allel β-sheet and C-terminal appendage from
MjCsm3 and (2) β6 and β7 from MjCsm4 interact
with a β2–β3 hairpin in MjCsm3 (Fig. 4, this work)
[23]. Interestingly, the residues that contribute to
these interface interactions were not well conserved,
suggesting that although the general interface is
conserved, the detailed interactions may vary
considerably among species, although this
notion would benefit from further investigation by
site-directed mutagenesis. Another key feature
noted in the MjCsm3–MjCsm4 complex was the
presence of an aligned basic concave surface
possibly involved in nucleic acid binding.
Numata et al. next investigated RNA binding by
the MjCsm3–MjCsm4 subcomplex and its constitu-
ent components using a 43-mer crRNA from the
M. jannaschiiCRISPR locus; a second 36-mer random
ssRNA (single-stranded RNA) served as the negative
control. Considering that Csm4 is a Cas5 ortholog, it
was expected that MjCsm4would bind preferentially to
the 5′ handle of the 43-mer crRNA. Surprisingly, they
were unable to detect any preference for the crRNAover the random ssRNA in their MjCsm3–MjCsm4
complex, suggesting that the complex binds ssRNA
in a non-sequence-specific manner. Further analysis
suggested that MjCsm4 contributed to most of the
nonspecific RNA-binding affinity, and MjCsm3 did not
appear to bind to either RNA substrate. Lack of
RNA-binding affinity in MjCsm3 was also surprising
because Csm3 from two other organisms, MkCsm3
and Staphylococcus epidermidis Csm3 (SeCsm3),
were shown to interact strongly with ssRNA [15,17].
The authors propose that this discrepancy could be
due to species-specific behavior of MjCsm3 or that
MjCsm3 may exhibit RNA binding in the context of the
complete Csm complex.
The MjCsm1–MjCsm4–MjCsm3 Ternary
Complex Model Provides Further Insight
about the Mechanism of Interference in
Type III-A CRISPR Systems
Previous work on the type III-B system defined the
structure of the Cmr2–Cmr3 subcomplex and its
interaction with the Cmr4 through both crystallograph-
ic and electron microscopy approaches [18,22].
Combined, these studies helped us to illustrate the
foot of the complex and its interaction with the helical
Cmr4 backbone. Armed with this previous structural
data, as well as the currently determined MjCsm3–
MjCsm4 structural fragment, the authors cleverly
recognized an opportunity to construct a model of
the MjCsm1–MjCsm4–MjCsm3 ternary complex. The
MjCsm3–MjCsm4 structure bridges the gaps in
understanding how the foot in the type III-A complex
is constructed and how it connects to the Csm3
backbone. MjCsm4 and Cmr3 can be classified
bioinformatically as Cas5 proteins, while MkCsm1
and Cmr2 are classified as Cas10 proteins [3]. Based
on this classification, the authors utilized the Cmr2–
Cmr3 structure [22] and superposed Cmr3 with
MjCsm4. It logically followed that the resulting
placement of Cmr2 should represent the location of
MjCsm1 in relation toMjCsm4. This structural analysis
presented a β-hairpin in Cmr3 that interacts with theD1
domain of Cmr2. Moreover, the Cmr3 β-hairpin was
conserved in MjCsm4, suggesting that it is responsible
for the interaction with MjCsm1. The resulting model
of the Csm1–Csm4–Csm3 complex illustrated a large
cleft with Csm4 forming the bottom and with Csm1 and
Csm3 forming the walls. As previously suggested, the
P. furiosusCsmcomplexelectronmicroscopy structure
illustrated the assembly of Csm1, Csm3 and Csm4
at the foot of the interference complex [16], which is
consistent with the MkCsm1–MkCsm4–MkCsm3
model. Numata et al. proposed that these proteins
are responsible for binding the 5′ handle of the
crRNA due to a recent biochemical experiment in the
P. furiosus Cmr complex in which the 5′ handle of the
crRNA is located adjacent to Cmr3 (corresponding to
230 Commentary about the III-A CRISPR PuzzleMjCsm4), while the immediately adjacent spacer
sequence was located near both Cmr2 (correspond-
ing to MjCsm1) and Cmr3 [18]. This fact could help to
support the possibility thatMjCsm4binds the 5′handle
of crRNA specifically in the context of the complex
but also binds ssRNA non-specifically as a single
component. Although MjCsm3 did not bind RNA as a
single component, the ternary complex model illus-
trated that residue H23 of MjCsm3 is located at the
edge of the concave surface and the corresponding
residue fromMkCsm3, Arg21, is critical for interaction
with ssRNA [17,23].Conclusions
The authors have conducted a quite interesting
structural study on theMjCsm complex that brings new
insights to the understanding of type III CRISPR
systems. The MjCsm3–MjCsm4 model provided
higher-resolution information for the assembly of this
subcomplex and allowed for the generation of a
ternary complex model including MjCsm1. The
analysis of this complex in conjunction with the
previously established electron microscopy models
helps us to suggest the function of the components
within the interference complex. Future directions
could include docking the MjCsm ternary complex
into the available electron microscopy structures to
further cross-validate the model. Further biochemical
studies could also be utilized to probe the potential
species-specific behavior of Csm3 proteins and better
define the mechanistic roles of Csm3 and Csm4.Acknowledgements
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